Polyclonality in malignant tumors as identified by DNA flow cytometry

W. Hiddemann,D. B. Bassewitz,A. Roessner,T. Büchner,E. Grundmann

DOI: https://doi.org/10.1007/BF02580118

1986-02-01

Journal of Cancer Research and Clinical Oncology

Abstract:

What problem does this paper attempt to address?

Bleeding and Thrombotic Complications in COVID-19-Associated ARDS Requiring ECMO

Eduardo P Tavares,José R Rebolo,Rodrigo Pimentel,Roberto L Roncon-Albuquerque Jr

DOI: https://doi.org/10.4187/respcare.10348

Abstract:Background: We analyzed bleeding and thrombotic complications in COVID-19-associated ARDS requiring extracorporeal membrane oxygenation (ECMO). Methods: This was a single-center observational study of adult subjects undergoing ECMO for COVID-19 (n = 67) or all other cause of ARDS (n = 60), excluding trauma patients. Results: In the COVID-19 group, duration of invasive mechanical ventilation prior to ECMO was lower (2 [0-4] d vs 3 [1-6] d) and ECMO retrieval less frequent (71% vs 87%). No significant differences were found in Simplified Acute Physiology Score II, Acute Physiology and Chronic Health Evaluation II (APACHE II), or in the in-hospital survival predicted by the Respiratory ECMO Survival Prediction score. During the first 7 d of ECMO support, the COVID-19 group presented higher platelets and fibrinogen, lower activated partial thromboplastin time, but no differences in D-dimer. Thrombotic complications were similar between groups. Higher rates of severe bleeding, namely airway bleeding (37.3% vs 15.0%) and hemothorax (13.4% vs 3.3%), were found in COVID-19, with lower hemoglobin and higher red blood cell transfusions. COVID-19 ARDS was associated with longer ECMO duration (47 [17-80] d vs 19 [12-30] d) and absence of a statistically significant difference concerning in-hospital mortality. Conclusions: COVID-19-associated ARDS requiring ECMO presented high rates of severe bleeding complications and a protracted course. Further studies are needed to clarify the risks and benefits of ECMO in severe COVID-19-associated ARDS.
Hemorrhage and thrombosis in COVID-19-patients supported with extracorporeal membrane oxygenation: an international study based on the COVID-19 critical care consortium

Maximilian Feth,Natasha Weaver,Robert B Fanning,Sung-Min Cho,Matthew J Griffee,Mauro Panigada,Akram M Zaaqoq,Ahmed Labib,Glenn J R Whitman,Rakesh C Arora,Bo S Kim,Nicole White,Jacky Y Suen,Gianluigi Li Bassi,Giles J Peek,Roberto Lorusso,Heidi Dalton,John F Fraser,Jonathon P Fanning,COVID-19 Critical Care Consortium,Heidi J Dalton,John Laffey,Daniel Brodie,Eddy Fan,Antoni Torres,Davide Chiumello,Alyaa Elhazmi,Carol Hodgson,Shingo Ichiba,Carlos Luna,Srinivas Murthy,Alistair Nichol,Pauline Yeung Ng,Mark Ogino,Eva Marwali,Giacomo Grasselli,Robert Bartlett,Aidan Burrell,Muhammed Elhadi,Anna Motos,Ferran Barbé,Alberto Zanella

DOI: https://doi.org/10.1186/s40560-024-00726-2

2024-05-06

Abstract:Background: Extracorporeal membrane oxygenation (ECMO) is a rescue therapy in patients with severe acute respiratory distress syndrome (ARDS) secondary to COVID-19. While bleeding and thrombosis complicate ECMO, these events may also occur secondary to COVID-19. Data regarding bleeding and thrombotic events in COVID-19 patients on ECMO are sparse. Methods: Using the COVID-19 Critical Care Consortium database, we conducted a retrospective analysis on adult patients with severe COVID-19 requiring ECMO, including centers globally from 01/2020 to 06/2022, to determine the risk of ICU mortality associated with the occurrence of bleeding and clotting disorders. Results: Among 1,248 COVID-19 patients receiving ECMO support in the registry, coagulation complications were reported in 469 cases (38%), among whom 252 (54%) experienced hemorrhagic complications, 165 (35%) thrombotic complications, and 52 (11%) both. The hazard ratio (HR) for Intensive Care Unit mortality was higher in those with hemorrhagic-only complications than those with neither complication (adjusted HR = 1.60, 95% CI 1.28-1.99, p < 0.001). Death was reported in 617 of the 1248 (49.4%) with multiorgan failure (n = 257 of 617 [42%]), followed by respiratory failure (n = 130 of 617 [21%]) and septic shock [n = 55 of 617 (8.9%)] the leading causes. Conclusions: Coagulation disorders are frequent in COVID-19 ARDS patients receiving ECMO. Bleeding events contribute substantially to mortality in this cohort. However, this risk may be lower than previously reported in single-nation studies or early case reports. Trial registration ACTRN12620000421932 ( https://covid19.cochrane.org/studies/crs-13513201 ).
Hemostasis During Extracorporeal Membrane Oxygenation: More Questions

Lin Chen,Zhongheng Zhang,Kun Chen

DOI: https://doi.org/10.1016/j.healun.2020.08.011

2020-01-01

Abstract:We read the study by Durila et al 1 Durila M, Vajter J, Garaj M, et al. Acquired primary hemostasis pathology detected by platelet function analyzer 200 seen during extracorporeal membrane oxygenation is sufficient to prevent circuit thrombosis: a pilot study. J Heart Lung Transplant. 2020;39:980-982. Google Scholar with interest; however, we seek several clarifications. First, a separate study by Yu et al 2 Yu ES, Jeon MJ, Kang KW, et al. The role of platelet function analyzer-200 in predicting perioperative bleeding risk [e-pub ahead of print]. Korean J Intern Med. doi:10.3904/kjim.2019.112, accessed September 9, 2020. Google Scholar showed that the results of platelet function analyzer 200 (PFA 200) are influenced by various factors, such as the use of aspirin and other non-steroidal anti-inflammatory agents, blood group type, hematocrit and time of blood collection, transfusions, and underlying diseases. The severity of surgery might cause bleeding, which affects collagen–epinephrine and collagen–adenosine diphosphate. The conclusion that the pathology of primary hemostasis detected by the PFA 200 (collagen–epinephrine and collagen–adenosine diphosphate) was specific for the extracorporeal membrane oxygenation (ECMO) phase of surgery is not robust and is subject to confounding bias. 3 Zhang Z Model building strategy for logistic regression: purposeful selection. Ann Transl Med. 2016; 4: 111 Crossref PubMed Scopus (192) Google Scholar Second, a continuous intravenous infusion of low-molecular-weight heparin was used to prevent venous thromboprophylaxis, but without dose described. Piwowarczyk et al 4 Piwowarczyk P, Borys M, Kutnik P, et al. Unfractionated heparin versus subcutaneous nadroparin in adults supported with venovenous extracorporeal membrane oxygenation: a retrospective, multicenter study [e-pub ahead of print]. ASAIO J. doi:10.1097/MAT.0000000000001166, accessed September 9, 2020. Google Scholar compared nadroparin with unfractionated heparin during veno-venous ECMO and found no significant difference in the number of thrombotic and hemorrhagic events. In the paper by Durila et al, 1 Durila M, Vajter J, Garaj M, et al. Acquired primary hemostasis pathology detected by platelet function analyzer 200 seen during extracorporeal membrane oxygenation is sufficient to prevent circuit thrombosis: a pilot study. J Heart Lung Transplant. 2020;39:980-982. Google Scholar even with the use of continuous intravenous infusion of low-molecular-weight heparin, 2 patients suffered thrombotic events. Third, the duration of the ECMO in their work is short (5 ± 3 days). The effect of duration of support on outcomes was not provided because we would suggest that the risk of thrombotic events is lower with a shorter duration of ECMO support. Given these considerations, it is difficult for us to completely agree with the conclusion that the PFA 200 analyzer may be used to prevent circuit thrombosis instead of using unfractionated heparin in patients on prolonged ECMO. We believe that a point-of-care test such as the PFA 200 may assist in adjusting anti-coagulant strategy to potentially reduce the use of unfractionated heparin rather than to prevent circuit thrombosis and obviate the use of unfractionated heparin altogether, especially in patients on prolonged ECMO support.
Bleeding Complications in COVID-19 Critically Ill ARDS Patients Receiving VV-ECMO Therapy

Armin Niklas Flinspach,Dorothée Bobyk,Kai Zacharowski,Vanessa Neef,Florian Jürgen Raimann

DOI: https://doi.org/10.3390/jcm12196415

2023-10-09

Abstract:Veno-venous extracorporeal membrane oxygenation (VV-ECMO) therapy is rapidly expanding worldwide, yet this therapy has a serious risk of bleeding. Whether coagulation-activating viral infections such as COVID-19 may have an impact on the risk of bleeding is largely unknown. This study conducted a monocentric investigation of severely affected COVID-19 patients receiving VV-ECMO therapy with regard to the occurrence and possible influences of minor and major bleeding and transfusion requirements. Among the 114 included study patients, we were able to assess more than 74,000 h of VV-ECMO therapy. In these, 103 major bleeding events and 2283 minor bleeding events were detected. In total, 1396 red blood concentrates (RBCs) were administered. A statistically significant correlation with the applied anticoagulation or demographic data of the patients was not observed. Contrary to the frequently observed thromboembolic complications among COVID-19 patients, patients with VV-ECMO therapy, even under low-dose anticoagulation, show a distinct bleeding profile, especially of minor bleeding, with a substantial need for blood transfusions. COVID-19 patients show a tendency to have frequent bleeding and require repeated RBC transfusions during VV-ECMO. This fact might not be solely explained by the mechanical alteration of ECMO or anticoagulation.
Impact of major bleeding and thrombosis on 180‐day survival in patients with severe COVID‐19 supported with veno‐venous extracorporeal membrane oxygenation in the United Kingdom: a multicentre observational study

Deepa J. Arachchillage,Indika Rajakaruna,Ian Scott,Mihaela Gaspar,Zain Odho,Winston Banya,Aikaterini Vlachou,Graziella Isgro,Lenka Cagova,Joshua Wade,Lucy Fleming,Mike Laffan,Richard Szydlo,Stephane Ledot,Rachel Jooste,Alain Vuylsteke,Hakeem Yusuff

DOI: https://doi.org/10.1111/bjh.17870

2021-10-07

British Journal of Haematology

Abstract:Bleeding and thrombosis are major complications in patients supported with extracorporeal membrane oxygenation (ECMO). In this multicentre observational study of 152 consecutive patients (≥18 years) with severe COVID-19 supported by veno-venous (VV) ECMO in four UK commissioned centres during the first wave of the COVID-19 pandemic (1 March to 31 May 2020), we assessed the incidence of major bleeding and thrombosis and their association with 180-day mortality. Median age (range) was 47 years (23–65) and 75% were male. Overall, the 180-day survival was 70·4% (107/152). The rate of major bleeding was 30·9% (47/152), of which intracranial bleeding (ICH) was 34% (16/47). There were 96 thrombotic events (63·1%) consisting of venous 44·7% [68/152 of which 66·2% were pulmonary embolism (PE)], arterial 18·6% (13/152) and ECMO circuit thrombosis 9·9% (15/152). In multivariate analysis, only raised lactate dehydrogenase (LDH) at the initiation of VV ECMO was associated with an increased risk of thrombosis [hazard ratio (HR) 1·92, 95% CI 1·21-3·03]. Major bleeding and ICH were associated with 3·87-fold (95% CI 2·10–7·23) and 5·97-fold [95% confidence interval (CI) 2·36–15·04] increased risk of mortality and PE with a 2·00-fold (95% CI1·09–3·56) risk of mortality. This highlights the difficult balancing act often encountered when managing coagulopathy in COVID-19 patients supported with ECMO.

hematology
Micronucleus scoring in liver fine needle aspiration cytology

Chien-Hui Wen,C. Lin,Shu-Chuan Tsao,Y. Su,Meng-Han Tsai,C.‐Y. Chai

DOI: https://doi.org/10.1111/cyt.12009

2013-12-01

Cytopathology

Abstract:C.‐H. Wen, C.‐H. Lin, S.‐C. Tsao, Y.‐C. Su, M.‐H. Tsai and C.‐Y. Chai  Micronucleus scoring in liver fine needle aspiration cytology
Radio frequency radiation (RFR) from radio antennas

B. Sırav,N. Seyhan

DOI: https://doi.org/10.1109/ICSMC2.2003.1429141

2003-05-11

Abstract:For the last 30 years, biological effects of non-ionizing radiation (NIR: 0-300 GHz) has got the top position in the scientific area, since a large population of the people are exposed to these fields. In this study, we evaluated the radio frequency radiation (RFR) at a pilot region located in Yenimahalle Sentepe Dededoruk Hill, in Ankara, Turkey. There are 64 different TV and radio towers and one base station at that region. With this study we calculated RFR of 14 radio transmitters. Although the base station, TV transmitters and some of radio transmitters are not included in the calculations, the radiation is found 388% more than the permitted standard values of Turkey.
Tissue hypersensitivity to dental materials.

B. Dahl

DOI: https://doi.org/10.1111/J.1365-2842.1978.TB01203.X

1978-04-01

Journal of Oral Rehabilitation

Abstract:Five cases of tissue hypersensitivity to Scutan and two to Impregum are reported. The reaction to Scutan was a burning sensation in the mucosa in contact with the material, followed by swelling and erythematous ulcers producing heavy discomfort. All symptoms gradually disappeared after removal of the material. To Impregum the reaction was basically the same, only less vigorous since contact with the material is of limited duration. All the cases were women in the menopause. Attention is drawn to the possibility of hormonal imbalance being a factor of importance in the development of hypersensitivity reactions to materials of this sort.
Influenceof Atelectasison Pulmonary FunctionAfter CoronaryArtery Bypass Grafting *

F. Vargas,A. Cukier,M. Terra-Filho,W. Hueb,L. Teixeira,R. Light,C. F.C.

Abstract:and pleural8(14.5%)19 (27.1%)27(21.6%)changes The purpose of this study was to determine the influence of atelectasis on pulmonary function 6 days following coronary artery bypass grafting (CABG). After 6 days, 30 patients had normal chest radiographs, 38 had atelectasis, and 57 had pleural changes. In 11 patients, atelectasis only was observed in the radiograph, and in 27 it was in combination with pleural changes. The decrease in FVC and FEy in the patients with atelectasis was 33.4 and 33.5 percent in the SVG group and 34.8 and 34.3 percent in the IMA group, while in those patients with a normal radio graph, the decrements were 26.3 and 26.9 percent in SVG group and 26. 1 and 26.9 percent in IMA group, respectively. Thus, patients with atelectasis on the 6th postoperative day have a larger decrement in pulmonary function post CABG than the patients with normal chest radiograph and this reduction reflects a higher degree of thoracic trauma. (Chest 1993; 104:434-37)
Fibrinolysis as a causative mechanism for bleeding complications on ECMO: a pilot observational prospective study

Julie Helms,Anaïs Curtiaud,François Severac,Marine Tschirhart,Hamid Merdji,Matthieu Bourdin,Geneviève Contant,François Depasse,Ramy Abou Rjeily,Laurent Sattler,Ferhat Meziani,Eduardo Angles-Cano

DOI: https://doi.org/10.1097/aln.0000000000004980

IF: 8.986

2024-03-19

Anesthesiology

Abstract:Background Extracorporeal membrane oxygenation (ECMO) is associated with a high risk of bleeding complications. The specific impact of ECMO on fibrinolysis remains unexplored. The objective of the current pilot observational prospective study was to investigate the longitudinal dynamics of fibrinolytic markers – i.e., changes over time - in the context of bleeding events in patients on ECMO. Methods Longitudinal dynamics of contact phase components (kininogen and bradykinin) and fibrinolysis markers (tissue-type plasminogen activator [t-PA], plasminogen activator inhibitor-1 [PAI-1], their complexes [t-PA•PAI-1], plasmin-antiplasmin complexes, plasminogen, and D-dimer) were measured in patients undergoing veno-venous and veno-arterial ECMO, before implantation, at 0, 6, and 12 hours post-implantation, and daily thereafter. Results The cohort consisted of 30 patients (214 ECMO-days). The concentrations of t-PA, D-dimer, plasmin-antiplasmin complexes, PAI-1 and t-PA•PAI-1 complexes were increased, whereas plasminogen decreased compared to normal values. A noteworthy divergence was observed between hemorrhagic and non-hemorrhagic patients: in bleeding patients, D-dimer, plasmin-antiplasmin, t-PA, PAI-1 and t-PA•PAI-1 followed an increasing kinetics before hemorrhage and then decreased to their baseline level; conversely non-bleeding patients showed a decreasing kinetics in these markers. Also, D-dimer and t-PA followed an increasing kinetics in bleeding patients compared to non-bleeding patients (median values for D-dimer dynamics: 1080 vs. -440 ng/mL, p=0.05; t-PA dynamics: 0.130 vs. 0.100 nM, p=0.038), and both markers significantly increased the day before hemorrhage. A t-PA concentration above 0.304 nM was associated with bleeding events (OR 4.92, 95% CI [1.01-24.08], p=0.049). Conclusion Contact activation induces fibrinolysis in ECMO patients, especially in patients experiencing bleeding. This finding supports the role of this mechanism as a possible causal factor for hemorrhages during ECMO and open new avenues for novel therapeutic perspectives. What we already know about this topic: Extracorporeal membrane oxygenation (ECMO) is associated with a high risk of bleeding complications due to multiple factors. However, the role of the fibrinolytic system is not well understood in this setting. What this article tells us that is new: In patients requiring cardiac and/or pulmonary support with ECMO, D-dimer and tissue plasminogen activator levels were increased with bleeding, findings consistent with fibrinolysis. Although there are multiple causes for fibrinolysis during ECMO, their study suggests that patients who bled had increased contact activation, and may benefit from novel therapeutic agents that inhibit hemostatic activation through this pathway.

anesthesiology
Electrical activation and electrical properties of arsenic-doped Hg 1-xCdxTe epilayers grown by MBE

Y. Selamet,G. Badano,C. Grein,P. Boieriu,V. Nathan,S. Sivananthan

DOI: https://doi.org/10.1117/12.448162

2001-11-12

Abstract:The annealing and electrical properties of extrinsic in situ doped mercury cadmium telluride epilayers grown by molecular beam epitaxy (MBE) on B CdTe/Si and CdZnTe substrates are studied. The doping is performed with an elemental arsenic source. HgCdTe epilayers of CdTe mole fraction in the range of mid-wavelength IR are grown at substrate temperatures of 175-185 degrees C. The temperature dependent Hall effect characteristics of the grown samples are measured by the van der Pauw technique. A magnetic field of up to 0.8 T is used in these measurements. The analysis of the Hall coefficient in the temperature range of 40-300 K with a fitting based on a three-band non-parabolic Kane model, a fully ionized compensating donor concentration, and tow independent discrete acceptor levels is reported. Both as-grown and annealed samples are used in this study. All of the as-grown samples showed-type characteristics whereas annealed samples showed p-type characteristics. Activation annealing at different temperatures was performed. Conversion to p-type at lower than conventional annealing temperatures was achieved. Theoretical models are utilized to understand the dependence of the activated arsenic concentration on the annealing temperature.
Grain determination for parallel processing systems

B. Kruatrachue,T. Lewis

DOI: https://doi.org/10.1109/HICSS.1988.11797

Abstract:A method of parallel-program optimization called grain packing is introduced that reduces total execution time of a parallel program by balancing execution time and communication time. The new method is applicable to both extended serial and concurrent programming languages, and can be used in languages such as OCCAM, Fortran, and Pascal. It is shown by example that two misconceptions common among programmers can lead to nonoptimal use of parallel processors: (1) load balancing does not give optimal performance in all cases, and (2) explicit parallel constructions in programming languages often lead to nonoptimal partitioning of parallel programs. Grain packing, along with an optimizing scheduler, gives consistently better results than human-engineered scheduling and packing.<<ETX>>
COVID-19 and ECMO: the interplay between coagulation and inflammation—a narrative review

Mariusz Kowalewski,Dario Fina,Artur Słomka,Giuseppe Maria Raffa,Gennaro Martucci,Valeria Lo Coco,Maria Elena De Piero,Marco Ranucci,Piotr Suwalski,Roberto Lorusso

DOI: https://doi.org/10.1186/s13054-020-02925-3

IF: 15.1

2020-05-08

Critical Care

Abstract:Abstract Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has presently become a rapidly spreading and devastating global pandemic. Veno-venous extracorporeal membrane oxygenation (V-V ECMO) may serve as life-saving rescue therapy for refractory respiratory failure in the setting of acute respiratory compromise such as that induced by SARS-CoV-2. While still little is known on the true efficacy of ECMO in this setting, the natural resemblance of seasonal influenza’s characteristics with respect to acute onset, initial symptoms, and some complications prompt to ECMO implantation in most severe, pulmonary decompensated patients. The present review summarizes the evidence on ECMO management of severe ARDS in light of recent COVID-19 pandemic, at the same time focusing on differences and similarities between SARS-CoV-2 and ECMO in terms of hematological and inflammatory interplay when these two settings merge.

critical care medicine
Blood purification therapy in patients with severe COVID-19 requiring veno-venous ECMO therapy: A retrospective study

Ali Akil,Stephan Ziegeler,Stephanie Rehers,Erik Christian Ernst,Stefan Fischer

DOI: https://doi.org/10.1177/03913988221103287

2022-06-15

Abstract:The International Journal of Artificial Organs, Ahead of Print. Objective:Patients with severe manifestations of COVID-19 might exhibit characteristics of a sepsis-like syndrome that can progress to multiple organ failure and ultimately death. Underlying mechanism have been explored and suggest a profound dysregulation of the immune system associated with hyperinflammation, hemodynamic instability and respiratory failure. Besides standard intensive care treatment, approaches modulating the dysregulated immune response, such as CytoSorb hemoadsorption, have been used. However, data of ECMO-dependent patients in comparison to a control cohort remain scarce.Methods:Included were 26 critically ill COVID-19 patients requiring high-flow veno-venous extracorporeal membrane oxygenation (high-flow VV ECMO) therapy due to severe acute respiratory distress syndrome (ARDS), of whom 16 were additionally treated with an extracorporeal hemoadsorption device, and compared to a control group of 10 patients. Assessed were levels of inflammatory markers, vasopressor requirements, oxygenation parameters, as well as clinically relevant outcome variables. Data were prospectively recorded and retrospectively analyzed.Results:Treatment with the applied multimodal therapy approach resulted in a stabilization in hemodynamics, a control of the hyperinflammatory response as evidenced by a significant reduction in inflammatory mediators, as well as a marked improvement in lung function. No device related adverse events were observed while treatment appeared safe and feasible.Conclusion:Treatment of a critically ill COVID-19 ARDS patients with combined VV ECMO support and hemoadsorption therapy led to a rapid and sustained hemodynamic stabilization, a control of the uncontrolled inflammatory response and an improvement in oxygenation. Given these signals pointing toward a patient-oriented benefit of extracorporeal hemoadsorption therapy in those patients, future controlled, randomized studies should focus on the investigation of the appropriate timing and dosing of this promising treatment modality.

engineering, biomedical,transplantation
Probabilistic models for daily peak loads at distribution feeders

H. Sangrody,Ning Zhou,Xingye Qiao

DOI: https://doi.org/10.1109/PESGM.2017.8274629

2017-03-19

Abstract:Load forecasting at distribution networks is more challenging than load forecasting at transmission networks because its load pattern is more stochastic and unpredictable. To plan sufficient resources and estimate DER hosting capacity, it is invaluable for a distribution network planner to get the probabilistic distribution of daily peak-load under a feeder over long term. In this paper, we model the probabilistic distribution functions of daily peak-load under a feeder using power law distributions, which is tested by improved Kolmogorov-Smirnov test enhanced by the Monte Carlo simulation approach. In addition, the uncertainty of the modeling is quantified using the bootstrap method. The methodology of parameter estimation of the probabilistic model and the hypothesis test is elaborated. In the case studies, it is shown using measurement data sets that the daily peak-loads under several feeders follow the power law distribution by applying the proposed testing methods.
Complications during Veno-Venous Extracorporeal Membrane Oxygenation in COVID-19 and Non-COVID-19 Patients with Acute Respiratory Distress Syndrome

Andrea Bruni,Caterina Battaglia,Vincenzo Bosco,Corrado Pelaia,Giuseppe Neri,Eugenio Biamonte,Francesco Manti,Annachiara Mollace,Annalisa Boscolo,Michele Morelli,Paolo Navalesi,Domenico LaganÃ,Eugenio Garofalo,Federico Longhini,IMAGE Group

DOI: https://doi.org/10.3390/jcm13102871

IF: 3.9

2024-05-14

Journal of Clinical Medicine

Abstract:Background: Acute respiratory distress syndrome (ARDS) presents a significant challenge in critical care settings, characterized by compromised gas exchange, necessitating in the most severe cases interventions such as veno-venous extracorporeal membrane oxygenation (vv-ECMO) when conventional therapies fail. Critically ill ARDS patients on vv-ECMO may experience several complications. Limited data exist comparing complication rates between COVID-19 and non-COVID-19 ARDS patients undergoing vv-ECMO. This retrospective observational study aimed to assess and compare complications in these patient cohorts. Methods: We retrospectively analyzed the medical records of all patients receiving vv-ECMO for ARDS between March 2020 and March 2022. We recorded the baseline characteristics, the disease course and complication (barotrauma, bleeding, thrombosis) before and after ECMO cannulation, and clinical outcomes (mechanical ventilation and ECMO duration, intensive care unit, and hospital lengths of stay and mortalities). Data were compared between COVID-19 and non-COVID-19 patients. In addition, we compared survived and deceased patients. Results: Sixty-four patients were included. COVID-19 patients (n = 25) showed higher rates of pneumothorax (28% vs. 8%, p = 0.039) with subcutaneous emphysema (24% vs. 5%, p = 0.048) and longer non-invasive ventilation duration before vv-ECMO cannulation (2 [1; 4] vs. 0 [0; 1] days, p = <0.001), compared to non-COVID-19 patients (n = 39). However, complication rates and clinical outcomes post-vv-ECMO were similar between groups. Survival analysis revealed no significant differences in pre-vv-ECMO complications, but non-surviving patients had a trend toward higher complication rates and more pleural effusions post-vv-ECMO. Conclusions: COVID-19 patients on vv-ECMO exhibit higher pneumothorax rates with subcutaneous emphysema pre-cannulation; post-cannulation complications are comparable to non-COVID-19 patients.

medicine, general & internal
Suppression of Fibrinolysis and Hypercoagulability, Severity of Hypoxemia, and Mortality in COVID-19 Patients: A Retrospective Cohort Study

Kristin M Corey,Lyra B Olson,Ibtehaj A Naqvi,Sarah A Morrison,Connor Davis,Shahid M Nimjee,Loretta G Que,Robin E Bachelder,Bryan D Kraft,Lingye Chen,Smita K Nair,Jerrold H Levy,Bruce A Sullenger

DOI: https://doi.org/10.1097/ALN.0000000000004239

IF: 8.986

2022-07-01

Anesthesiology

Abstract:Background: COVID-19 causes hypercoagulability, but the association between coagulopathy and hypoxemia in critically ill patients has not been thoroughly explored. This study hypothesized that severity of coagulopathy would be associated with acute respiratory distress syndrome severity, major thrombotic events, and mortality in patients requiring intensive care unit-level care. Methods: Viscoelastic testing by rotational thromboelastometry and coagulation factor biomarker analyses were performed in this prospective observational cohort study of critically ill COVID-19 patients from April 2020 to October 2020. Statistical analyses were performed to identify significant coagulopathic biomarkers such as fibrinolysis-inhibiting plasminogen activator inhibitor 1 and their associations with clinical outcomes such as mortality, extracorporeal membrane oxygenation requirement, occurrence of major thrombotic events, and severity of hypoxemia (arterial partial pressure of oxygen/fraction of inspired oxygen categorized into mild, moderate, and severe per the Berlin criteria). Results: In total, 53 of 55 (96%) of the cohort required mechanical ventilation and 9 of 55 (16%) required extracorporeal membrane oxygenation. Extracorporeal membrane oxygenation-naïve patients demonstrated lysis indices at 30 min indicative of fibrinolytic suppression on rotational thromboelastometry. Survivors demonstrated fewer procoagulate acute phase reactants, such as microparticle-bound tissue factor levels (odds ratio, 0.14 [0.02, 0.99]; P = 0.049). Those who did not experience significant bleeding events had smaller changes in ADAMTS13 levels compared to those who did (odds ratio, 0.05 [0, 0.7]; P = 0.026). Elevations in plasminogen activator inhibitor 1 (odds ratio, 1.95 [1.21, 3.14]; P = 0.006), d-dimer (odds ratio, 3.52 [0.99, 12.48]; P = 0.05), and factor VIII (no clot, 1.15 ± 0.28 vs. clot, 1.42 ± 0.31; P = 0.003) were also demonstrated in extracorporeal membrane oxygenation-naïve patients who experienced major thrombotic events. Plasminogen activator inhibitor 1 levels were significantly elevated during periods of severe compared to mild and moderate acute respiratory distress syndrome (severe, 44.2 ± 14.9 ng/ml vs. mild, 31.8 ± 14.7 ng/ml and moderate, 33.1 ± 15.9 ng/ml; P = 0.029 and 0.039, respectively). Conclusions: Increased inflammatory and procoagulant markers such as plasminogen activator inhibitor 1, microparticle-bound tissue factor, and von Willebrand factor levels are associated with severe hypoxemia and major thrombotic events, implicating fibrinolytic suppression in the microcirculatory system and subsequent micro- and macrovascular thrombosis in severe COVID-19.
At the Core: How We Steer Our Course

R. H. Klein

DOI: https://doi.org/10.1521/IJGP.55.2.229.62185

2005-03-01

International Journal of Group Psychotherapy

Abstract:Abstract The beautiful evocative words of Dylan Thomas speak to the driving life force that pulses through all creation. So what, then, drives our organization, the American Group Psychotherapy Association (AGPA)? What underlying stream can we tap into to provide the energy, power, and vitality we need to go on being in a meaningful and productive fashion? And, what internal compass can we rely on to steer us in the right direction, to guide us in how we function as an organization? My purpose here is to consider how we formulate our objectives, determine our priorities, make decisions, and insure, as best we can, that we are pursuing that which is meaningful and essential, not veering drastically off course. To do this, I would like to focus briefly on the current organizational structure of AGPA, then examine the use of a strategic planning process, review our accomplishments, and lastly explore hopes and dreams for our future as the premier group psychotherapy organization in the United States.
Observational study of thrombosis and bleeding in COVID-19 VV ECMO patients

Brianda Ripoll,Antonio Rubino,Martin Besser,Chinmay Patvardhan,William Thomas,Karen Sheares,Hilary Shanahan,Bobby Agrawal,Stephen Webb,Alain Vuylsteke

DOI: https://doi.org/10.1177/0391398821989065

2021-01-28

The International Journal of Artificial Organs

Abstract:Introduction: COVID-19 has been associated with increased risk of thrombosis, heparin resistance and coagulopathy in critically ill patients admitted to intensive care. We report the incidence of thrombotic and bleeding events in a single center cohort of 30 consecutive patients with COVID-19 supported by veno-venous extracorporeal oxygenation (ECMO) and who had a whole body Computed Tomography Scanner (CT) on admission. Methodology: All patients were initially admitted to other hospitals and later assessed and retrieved by our ECMO team. ECMO was initiated in the referral center and all patients admitted through our CT scan before settling in our intensive care unit. Clinical management was guided by our institutional ECMO guidelines, established since 2011 and applied to at least 40 patients every year. Results: We diagnosed a thrombotic event in 13 patients on the initial CT scan. Two of these 13 patients subsequently developed further thrombotic complications. Five of those 13 patients had a subsequent clinically significant major bleeding. In addition, two patients presented with isolated intracranial bleeds. Of the 11 patients who did not have baseline thrombotic events, one had a subsequent oropharyngeal hemorrhage. When analyzed by ROC analysis, the area under the curve for % time in intended anticoagulation range did not predict thrombosis or bleeding during the ECMO run (0.36 (95% CI 0.10–0.62); and 0.51 (95% CI 0.25–0.78); respectively). Conclusion: We observed a high prevalence of VTE and a significant number of hemorrhages in these severely ill patients with COVID-19 requiring veno-venous ECMO support.
The early decline in platelet count is associated with increased adverse outcomes in non heparin-induced thrombocytopenia pediatric patients undergoing VA-ECMO

Yu Jin,He Wang,Chun Zhou,Peiyao Zhang,Zhangyu Lin,Wenting Wang,Peng Gao,Jia Liu,Jinping Liu

DOI: https://doi.org/10.1177/02676591241301614

2024-11-23

Perfusion

Abstract:Perfusion, Ahead of Print. IntroductionThe impact of non heparin-induced thrombocytopenia on the clinical outcomes for pediatric cardiac surgery patients who required veno-arterial extracorporeal membrane support (VA-ECMO) for failure to wean from cardiopulmonary bypass (CPB) is uncertain. This study aimed to investigate the relationship between thrombocytopenia and prognosis in these patients.MethodsThis retrospective study enrolled 96 pediatric patients (age < 18) who received VA-ECMO directly transitioned from CPB at Fuwai Hospital from January 2010 to June 2020. The association between relative decrease in platelet count (△PLT) post-ECMO 24 h and clinical outcomes was explored.ResultsThere were significant differences in Post-ECMO 24 h platelet counts, platelet count nadir, and duration of platelet decline between the survivors and non-survivors in CPB-ECMO groups. A positive correlation was found between △PLT post-ECMO 24 h and plasma-free hemoglobin (pFHb) (p = .014, r = 0.305), peak serum creatinine (p = .016, r = 0.299), peak AST (p = .014, r = 0.302), duration of platelet transfusion (p = .032, r = 0.270),The △PLT post-ECMO 24 h had predictive value on in-hospital mortality [(p < .001, AUROC = 0.781 (95% CI: 0.670–0.892)], massive bleeding (p = .001, AUROC 95% CI: 0.627–0.870), hemolysis (p = .046, AUROC 95% CI: 0.510–0.780), and nosocomial infection (p = .020, AUROC 95% CI: 0.536–0.801). Multivariate logistic regression showed that △PLT post-ECMO 24 h was associated with in-hospital mortality and hemolysis.ConclusionsThe relative early decrease in platelet count 24 h following transition to ECMO is associated with increased patient mortality, and is positively associated with adverse outcomes in pediatric cardiac surgery patients transferred from CPB to ECMO. Moreover, this decline rate can predict in-hospital survival, major bleeding, hemolysis, and hospital-acquired infections.

cardiac & cardiovascular systems,peripheral vascular disease

Polyclonality in malignant tumors as identified by DNA flow cytometry

Bleeding and Thrombotic Complications in COVID-19-Associated ARDS Requiring ECMO

Hemorrhage and thrombosis in COVID-19-patients supported with extracorporeal membrane oxygenation: an international study based on the COVID-19 critical care consortium

Hemostasis During Extracorporeal Membrane Oxygenation: More Questions

Bleeding Complications in COVID-19 Critically Ill ARDS Patients Receiving VV-ECMO Therapy

Impact of major bleeding and thrombosis on 180‐day survival in patients with severe COVID‐19 supported with veno‐venous extracorporeal membrane oxygenation in the United Kingdom: a multicentre observational study

Micronucleus scoring in liver fine needle aspiration cytology

Radio frequency radiation (RFR) from radio antennas

Tissue hypersensitivity to dental materials.

Influenceof Atelectasison Pulmonary FunctionAfter CoronaryArtery Bypass Grafting *

Fibrinolysis as a causative mechanism for bleeding complications on ECMO: a pilot observational prospective study

Electrical activation and electrical properties of arsenic-doped Hg 1-xCdxTe epilayers grown by MBE

Grain determination for parallel processing systems

COVID-19 and ECMO: the interplay between coagulation and inflammation—a narrative review

Blood purification therapy in patients with severe COVID-19 requiring veno-venous ECMO therapy: A retrospective study

Probabilistic models for daily peak loads at distribution feeders

Complications during Veno-Venous Extracorporeal Membrane Oxygenation in COVID-19 and Non-COVID-19 Patients with Acute Respiratory Distress Syndrome

Suppression of Fibrinolysis and Hypercoagulability, Severity of Hypoxemia, and Mortality in COVID-19 Patients: A Retrospective Cohort Study

At the Core: How We Steer Our Course

Observational study of thrombosis and bleeding in COVID-19 VV ECMO patients

The early decline in platelet count is associated with increased adverse outcomes in non heparin-induced thrombocytopenia pediatric patients undergoing VA-ECMO